Paid Clinical Trials in Pennsylvania

Pennsylvania has 3,479 paid clinical trials enrolling now across cities including Philadelphia, Pittsburgh and Hershey. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Pennsylvania include Penn Medicine, Children's Hospital of Philadelphia and UPMC, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 4, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

3,012 clinical trials

Get a weekly email when new trials open in Philadelphia, PA.

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

for Haematological Malignancy

Sites in Philadelphia +5 more locations

Sponsor: CellCentric Ltd.

Sex: All·Age: 18+

Code: NCT04068597·Phase 1, Phase 2·Recruiting·Listed Aug 2019

Apply to this trial

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

for Prostate Cancer

Sites in Philadelphia +6 more locations

Sponsor: Amgen

Sex: Male·Age: 18+

Code: NCT06613100·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure

for Heart Failure With Reduced Ejection Fraction

Sites in Philadelphia +1 more location

Sponsor: VisCardia Inc.

Sex: All·Age: 18+

Code: NCT06552637·Recruiting·Listed Aug 2024

Apply to this trial

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

for Spasticity

Sites in Elkins Park +3 more locations

Sponsor: Ipsen

Sex: All·Age: 18 - 70

Code: NCT04752774·Phase 1, Phase 2·Recruiting·Listed Feb 2021

Apply to this trial

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

for Non Small Cell Lung Cancer

Sites in Paoli +8 more locations

Sponsor: N-Power Medicine

Sex: All·Age: 18+

Code: NCT07028489·Recruiting·Listed Jun 2025

Apply to this trial

A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

for Elevated Blood Pressure

Sites in Pittsburgh, Washington +8 more locations

Sponsor: Zona Health, Inc

Sex: All·Age: 22+

Code: NCT06843577·Recruiting·Listed Feb 2025

Apply to this trial

Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital

for COPD

Sites in Philadelphia +3 more locations

Sponsor: Fisher and Paykel Healthcare

Sex: All·Age: 22+

Code: NCT07222410·Recruiting·Listed Oct 2025

Apply to this trial

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

for Hemophilia A

Sites in Philadelphia +2 more locations

Sponsor: Pfizer

Sex: Male·Age: 1 - 74

Code: NCT05145127·Phase 3·Recruiting·Listed Dec 2021

Apply to this trial

An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease

for Vanishing White Matter Disease

Sites in Philadelphia +2 more locations

Sponsor: Calico Life Sciences LLC

Sex: All·Age: 6 Months+

Code: NCT05757141·Phase 1, Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

for Healthy Participants

Drug: PF-07832837

Sites in Philadelphia +4 more locations

Sponsor: Pfizer

Sex: All·Age: 18 - 70·Accepts healthy volunteers

Code: NCT06564389·Phase 1·Recruiting·Listed Aug 2024

Apply to this trial

A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4

for Congenital Myasthenic Syndrome

Sites in Philadelphia +5 more locations

Sponsor: argenx

Sex: All·Age: 2+

Code: NCT06078553·Recruiting·Listed Oct 2023

Apply to this trial

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

for Somatostatin Receptor Positive

Sites in Philadelphia +2 more locations

Sponsor: ITM Solucin GmbH

Sex: All·Age: 24 Months - 18

Code: NCT06441331·Phase 1·Recruiting·Listed Jun 2024

Apply to this trial

Radiation Free Study

for Aortic Aneurysm

Sites in Philadelphia +4 more locations

Sponsor: Philips Clinical & Medical Affairs Global

Sex: All·Age: 18+

Code: NCT06549348·Recruiting·Listed Aug 2024

Apply to this trial

Clinical Outcomes Study of the Nexel Total Elbow

for Elbow Joint Destruction

Sites in Philadelphia +3 more locations

Sponsor: Zimmer Biomet

Sex: All·Age: 18+

Code: NCT02469662·Recruiting·Listed Jun 2015

Apply to this trial

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

for Monoclonal Gammopathy of Undetermined Significance (MGUS)

Drug: Linvoseltamab

Sites in Philadelphia +6 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06140524·Phase 2·Recruiting·Listed Nov 2023

Apply to this trial

GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study

for Pelvic Organ Prolapse

Sites in Pittsburgh & North Wales

Sponsor: Ethicon, Inc.

Sex: Female·Age: 21+

Code: NCT04829058·Recruiting·Listed Apr 2021

Apply to this trial

Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry

for Stress Urinary Incontinence

Sites in Philadelphia, Pittsburgh +2 more locations

Sponsor: Ethicon, Inc.

Sex: Female·Age: 21+

Code: NCT04829175·Recruiting·Listed Apr 2021

Apply to this trial

Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System

for Stress Urinary Incontinence

1 location in North Wales

Sponsor: Ethicon, Inc.

Sex: Female·Age: 21+

Code: NCT04829357·Recruiting·Listed Apr 2021

Apply to this trial

A Study of Patients With Fabry Disease (US Specific)

for Fabry Disease

Sites in Pittsburgh +7 more locations

Sponsor: Amicus Therapeutics

Sex: All·Age: 18+

Code: NCT06906367·Recruiting·Listed Apr 2025

Apply to this trial

Aptis PRUJ Prosthesis for the Treatment of Patients With Proximal Radial Ulna Joint Disorders.

for Arthritis

Sites in Allentown +5 more locations

Sponsor: Aptis Medical

Sex: All·Age: 18 - 85·Accepts healthy volunteers

Code: NCT05796908·Recruiting·Listed Apr 2023

Apply to this trial

R-2487 in Patients With Rheumatoid Arthritis

for Arthritis, Rheumatoid

Sites in Duncansville +5 more locations

Sponsor: Rise Therapeutics LLC

Sex: All·Age: 18 - 75

Code: NCT05961592·Phase 1·Recruiting·Listed Jul 2023

Apply to this trial

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

for Healthy Participants

Sites in Philadelphia, Hershey +6 more locations

Sponsor: Equilibra Bioscience LLC

Sex: All·Age: 18 - 60·Accepts healthy volunteers

Code: NCT06349473·Phase 1·Recruiting·Listed Apr 2024

Apply to this trial

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

for Cervical Cancer

Sites in Pittsburgh +6 more locations

Sponsor: Orano Med Theranostics, SAS

Sex: All·Age: 18+

Code: NCT05283330·Phase 1·Recruiting·Listed Mar 2022

Apply to this trial

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

for Advanced Solid Tumor

Sites in Pittsburgh +4 more locations

Sponsor: Senhwa Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT04890613·Phase 1·Recruiting·Listed May 2021

Apply to this trial

Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis

for Generalized Myasthenia Gravis

Sites in Philadelphia +3 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 65

Code: NCT06704269·Phase 1, Phase 2·Recruiting·Listed Nov 2024

Apply to this trial

A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair

for Peripheral Nerve Injuries

Sites in Philadelphia +7 more locations

Sponsor: Auxilium Biotechnologies

Sex: All·Age: 18 - 80

Code: NCT06529835·Recruiting·Listed Jul 2024

Apply to this trial

Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Philadelphia +7 more locations

Sponsor: OncoC4, Inc.

Sex: All·Age: 18+

Code: NCT06352359·Phase 1·Recruiting·Listed Apr 2024

Apply to this trial

SPI-1005 in Adults Receiving Cochlear Implant

for Hearing Loss

Sites in Philadelphia +5 more locations

Sponsor: Sound Pharmaceuticals, Incorporated

Sex: All·Age: 18+

Code: NCT06340633·Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

for Acute Myeloid Leukemia

Sites in Easton +5 more locations

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT06824168·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems

for Peripheral Neuropathies

Sites in Pittsburgh +2 more locations

Sponsor: RxFunction Inc.

Sex: All·Age: 55+

Code: NCT06959277·Recruiting·Listed May 2025

Apply to this trial

A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia

for Friedreich Ataxia

Sites in Philadelphia +6 more locations

Sponsor: Biogen

Sex: All·Age: 2 - 15

Code: NCT06953583·Phase 3·Recruiting·Listed May 2025

Apply to this trial

Two Dose Levels of Privigen in Pediatric CIDP

for Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Sites in Philadelphia +2 more locations

Sponsor: CSL Behring

Sex: All·Age: 2 - 17

Code: NCT03684018·Phase 4·Recruiting·Listed Sep 2018

Apply to this trial

Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer

for Ovarian Cancer

Sites in Philadelphia +4 more locations

Sponsor: Nerviano Medical Sciences

Sex: Female·Age: 18+

Code: NCT06930755·Phase 1·Recruiting·Listed Apr 2025

Apply to this trial

Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)

for Leber Congenital Amaurosis 10

Sites in Philadelphia +4 more locations

Sponsor: Laboratoires Thea

Sex: All·Age: 6+

Code: NCT06891443·Phase 3·Recruiting·Listed Mar 2025

Apply to this trial

Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF)

for Ileal Pouch

Sites in Hershey +7 more locations

Sponsor: Exegi Pharma, LLC

Sex: All·Age: 18+

Code: NCT05938465·Phase 1, Phase 2·Recruiting·Listed Jul 2023

Apply to this trial

CT-95 in Advanced Cancers Associated With Mesothelin Expression

for Mesothelin-Expressing Tumors

Sites in Philadelphia +8 more locations

Sponsor: Context Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT06756035·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

Transdermal Compress IDE Study

for Prosthesis and Implants

Sites in Pittsburgh, Philidelphia +7 more locations

Sponsor: Balmoral Medical company

Sex: All·Age: 18 - 60

Code: NCT06134167·Recruiting·Listed Nov 2023

Apply to this trial

Clinical Study of the inQB8 TTVR System (The MonarQ Study)

for Tricuspid Valve Regurgitation

Sites in Philadelphia +5 more locations

Sponsor: inQB8 Medical Technologies, LLC

Sex: All·Age: 18+

Code: NCT06611579·Recruiting·Listed Sep 2024

Apply to this trial

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

for Primary Immunoglobulin A Nephropathy (IgAN)

Drug: Iptacopan

Sites in Philadelphia +2 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 2 - 18

Code: NCT06994845·Phase 3·Recruiting·Listed May 2025

Apply to this trial

Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy

for Diabetic Foot Ulcer

1 location in Monroeville

Sponsor: Sequence LifeScience, Inc.

Sex: All·Age: 18+

Code: NCT07086443·Phase 4·Recruiting·Listed Jul 2025

Apply to this trial